Article

Precise and efficient insertion of A673T mutation in APP gene using MSYM

2023-02-28

Abstract excerpt

<title>Abstract</title> <p>Alzheimer's Disease is a progressive neurodegenerative disorder characterized by toxic accumulation of amyloid beta peptides and tau neurofibrillary tangles. A673T mutation, as a protective mutation existing in natural people has a huge potential in the pharmacotherapy of Alzheimer's Disease, particularly for the combination with stem cell therapy, which may not only provide clinic bene...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e930a473-b2fb-5d1a-a9e1-675c50060022
DOI: 10.21203/rs.3.rs-2625740/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Precise and efficient insertion of A673T mutation in APP gene using MSYMDOI 10.21203/rs.3.rs-2625740/v1Read

Base editing strategy allows insertion of the A673T mutation in APP gene to prevent the development of Alzheimer’s diseaseSemantic proximity Read

Base editing strategy for insertion of the A673T mutation in the APP gene to prevent the development of AD in vitroSemantic proximity Read

Specific mutations in genes responsible for Alzheimer and for Duchenne Muscular Dystrophy introduced by Base editing and PRIME editingSemantic proximity Read

Insertion of the Icelandic Mutation (A673T) by Prime Editing: A Potential Preventive Treatment for Familial and Sporadic Alzheimer's Disease.Semantic proximity Read

Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9.Semantic proximity Read

SPLICER: A Highly Efficient Base Editing Toolbox That Enables <i>In Vivo</i> Therapeutic Exon SkippingSemantic proximity Read

Long term rescue of Alzheimer’s deficits <i>in vivo</i> by one-time gene-editing of <i>App</i> C-terminusSemantic proximity Read

A CRISPR/Cas9 based strategy to manipulate the Alzheimer’s amyloid pathwaySemantic proximity Read

Generation of a gene-corrected human isogenic iPSC line from an Alzheimer's disease iPSC line carrying the London mutation in APP (V717I).Semantic proximity Read

CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeuticsSemantic proximity Read

Application of CRISPR/Cas9 in the management of Alzheimer’s disease and Parkinson’s disease: a reviewSemantic proximity Read

CRISPR/Cas9 editing of APP C-terminus attenuates β-cleavage and promotes α-cleavageSemantic proximity Read